SightfileU.S. market data from official filings

Companies › LH

LABCORP HOLDINGS INC (LH)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000920148 · EDGAR filings · Updated 2026-07-10

LABCORP HOLDINGS INC (LH) has reported institutional ownership of 95.0%, with 1,015 institutional managers holding positions valued at $20.8B per the latest 13F reporting period. The company has 8 bond series in the registry.

Institutional ownership
95.0%
Institutional managers
1,015
Reported 13F value
$20.8B
Insider activity
154 trans.
−$16.8M net selling

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, LABCORP HOLDINGS INC has 1,015 institutional holders and institutional ownership of 95.0%.

#InstitutionReported value% of tracked total
1BlackRock, Inc.$1.72B8.3%
2VANGUARD CAPITAL MANAGEMENT LLC$1.43B6.9%
3VICTORY CAPITAL MANAGEMENT INC$1.23B5.9%
4STATE STREET CORP$1.03B5.0%
5VANGUARD PORTFOLIO MANAGEMENT LLC$982.0M4.7%
6Boston Partners$632.4M3.0%
7Allspring Global Investments Holdings, LLC$607.2M2.9%
8GEODE CAPITAL MANAGEMENT, LLC$581.0M2.8%
9Select Equity Group, L.P.$580.3M2.8%
10JPMORGAN CHASE & CO$404.0M1.9%

Full holder history and quarter-over-quarter changes are available inside the app.

Insider activity

Insiders reported 154 transactions (0 buys, 25 sells) across 22 reporting insiders, with a net reported value of −$16.8M.

Quarterly net insider value, as reported in Form 4 filings.

Debt profile

8 active bond series in the registry, coupons ranging 1.55%–4.80%, maturities through 2045, built from the company's own prospectus filings.

Debt maturity schedule

Principal coming due by year for LABCORP HOLDINGS INC, from the company's own SEC prospectus filings (424B) tracked by Sightfile.

YearBond series maturingKnown principal due
20261
20271
20291
20301$650.0M
20311
20321$500.0M
20341$850.0M
20451

Coupons, seniority and prospectus links for each series are available inside the app.

Related companies

RESMED INC (RMD) · ARGENX SE (ARGX) · STERIS PLC (STE) · GSK PLC (GSK) · QUEST DIAGNOSTICS INC (DGX) · ILLUMINA INC (ILMN)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-10.